BNP and Vascular Surgery
BNPinVasc
Evaluation of BNP Values in Major Vascular Surgery
1 other identifier
observational
165
1 country
1
Brief Summary
Background and rationale of the study: Patients undergoing non-cardiac major surgery show a perioperative cardiac risk and postoperative complications, that can be stratified based on parameters linked to patient's conditions and to surgery types. An accurate identification of this risk could offer numerous advantages for these patients, who's 30-day mortality is around 2%. The identification of the correct risk could lead to a better pre- and postoperative management, that could guarantee a better surgery outcome and a faster postoperative recovery. To this day there is no perfect method to correctly estimate this risk. Various studies show that high BNP levels are linked to cardiac events at 30 and 180 days. Further investigations identify different groups, at low, intermediate and high risk, based on BNP levels. BNP is released by ventricular myocytes in response to a wall distress, due to an increased volume, pressure or myocardial ischemia. So BNP plasma levels could be used as a prognostic and diagnostic marker, improving the cardiac risk stratification in patients undergoing surgery and a much more precise management. This study is determined to do an evaluation of the correlations between pre- and postoperative BNP levels and the incidence of cardiac events in patients undergoing major vascular surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2018
CompletedFirst Submitted
Initial submission to the registry
January 7, 2019
CompletedFirst Posted
Study publicly available on registry
April 24, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2020
CompletedApril 24, 2019
April 1, 2019
2 years
January 7, 2019
April 23, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of cardiac events
from the induction of general anesthesia until hospital discharge, an average of 1 week
Secondary Outcomes (6)
Incidence of postoperative pulmonary complication
from immediately after surgery until hospital discharge, an average of 1 week
Incidence of postoperative neurological complication
from immediately after surgery until hospital discharge, an average of 1 week
Incidence of postoperative acute kidney failure
from immediately after surgery until hospital discharge, an average of 1 week
Incidence of unplanned ICU admission
from immediately after surgery until hospital discharge, an average of 1 week
Hospital length of stay
from immediately after surgery until hospital discharge, an average of 1 week
- +1 more secondary outcomes
Eligibility Criteria
Adult undergoing major vascular surgery
You may qualify if:
- Ability to provide an informed consent
- Age \>18 years old
- Elective abdominal aortic aneurysm surgery
You may not qualify if:
- Emergency surgery
- Age ˂ 18 years old
- Creatinine \>2mg/dl
- Diseases of ascending aorta, aortic arch or thoracic aorta
- Chronic atrial fibrillation
- Patient refusal to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Elena Giovanna Bignami
Parma, 43126, Italy
Related Publications (5)
Vetrugno L, Orso D, Matellon C, Giaccalone M, Bove T, Bignami E. The Possible Use of Preoperative Natriuretic Peptides for Discriminating Low Versus Moderate-High Surgical Risk Patient. Semin Cardiothorac Vasc Anesth. 2018 Dec;22(4):395-402. doi: 10.1177/1089253217752061. Epub 2018 Jan 13.
PMID: 29332544BACKGROUNDWayne Causey M, Singh N. Clinical implications of B-type natriuretic peptide and N-terminal pro--B-type natriuretic peptide in the care of the vascular surgery patient. Semin Vasc Surg. 2014 Dec;27(3-4):143-7. doi: 10.1053/j.semvascsurg.2015.01.004. Epub 2015 Jan 21.
PMID: 26073822BACKGROUNDBiccard BM, Devereaux PJ, Rodseth RN. Cardiac biomarkers in the prediction of risk in the non-cardiac surgery setting. Anaesthesia. 2014 May;69(5):484-93. doi: 10.1111/anae.12635.
PMID: 24738805BACKGROUNDBryce GJ, Payne CJ, Gibson SC, Byrne DS, Delles C, McClure J, Kingsmore DB. B-type natriuretic peptide predicts postoperative cardiac events and mortality after elective open abdominal aortic aneurysm repair. J Vasc Surg. 2013 Feb;57(2):345-53. doi: 10.1016/j.jvs.2012.07.053. Epub 2012 Oct 9.
PMID: 23058722BACKGROUNDVetrugno L, Costa MG, Pompei L, Chiarandini P, Drigo D, Bassi F, Gonano N, Muzzi R, Della Rocca G. Prognostic power of pre- and postoperative B-type natriuretic peptide levels in patients undergoing abdominal aortic surgery. J Cardiothorac Vasc Anesth. 2012 Aug;26(4):637-42. doi: 10.1053/j.jvca.2012.01.018. Epub 2012 Mar 2.
PMID: 22387082BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
January 7, 2019
First Posted
April 24, 2019
Study Start
December 10, 2018
Primary Completion
December 10, 2020
Study Completion
December 10, 2020
Last Updated
April 24, 2019
Record last verified: 2019-04